{"nctId":"NCT03662789","briefTitle":"Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients","startDateStruct":{"date":"2018-04-25","type":"ACTUAL"},"conditions":["Heart Transplant Recipients"],"count":102,"armGroups":[{"label":"Iron isomaltoside 1000","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Iron Isomaltoside 1000"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo: NaCl 0,9%"]}],"interventions":[{"name":"Iron Isomaltoside 1000","otherNames":["Monofer B03AC-"]},{"name":"Placebo: NaCl 0,9%","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Cardiac allograft.\n* Presentation at least one year after heart transplantation.\n* Iron deficiency defined as serum ferritin \\< 100 µg/l or ferritin between 100 and 300 µg/l in combination with a transferrin saturation \\< 20 %.\n* Age between 18 and 80 years.\n* Informed consent obtained and documented according to Good Clinical Practice (GCP), and national/regional regulations.\n\nExclusion Criteria:\n\n* Anaemia (Haemoglobin \\< 100 mg/l)\n* Haemochromatosis\n* Haemosiderosis\n* Porphyria cutanea tarda\n* Blood dyscrasias or any disorders causing haemolysis or unstable red blood cells\n* Decompensated liver disease (Child-Pugh score 7 or higher)\n* End-stage renal failure, i.e. estimated glomerular filtration rate \\< 15 ml/min or on renal replacement therapy\n* Planned cardiac surgery or angioplasty within 6 months\n* Planned major surgery within 6 months\n* Medical history of unresolved cancer (except for basal cell carcinoma)\n* Treatment with systemic steroids more than the equivalent of 10 mg Prednisone/day at the time of informed consent or change in dosage of thyroid hormones within 6 weeks prior to informed consent\n* Any uncontrolled endocrine disorder except type 2 diabetes\n* Pregnancy\n* On erythropoietin analogues\n* Known sensitivity or intolerance to iron isomaltoside or other parenteral iron preparations\n* Intravenous iron supplement within 6 months prior to inclusion\n* On oral iron substitution (unless the subject agrees to stop treatment prior to randomisation)\n* Ongoing rejections or infections\n* Alcohol or drug abuse within 3 months of informed consent that would interfere with trial participation or any ongoing condition leading to decreased compliance with study procedures or study drug intake\n* Intake of an investigational drug in another trial within 30 days prior to intake of study medication in this trial or participating in another trial involving an investigational drug and/or follow-up","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Peak Oxygen Consumption","description":"The primary endpoint will be the baseline-adjusted between-group difference in peak oxygen consumption as measured on a treadmill exercise test","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23.9","spread":"6.6"},{"groupId":"OG001","value":"22.0","spread":"6.1"}]}]}]},{"type":"SECONDARY","title":"Iron Deficiency","description":"The number of patients with absolute or functional iron deficiency","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"40","spread":null}]}]}]},{"type":"SECONDARY","title":"Muscle Strength","description":"Baseline-adjusted muscle strength as measured by a hand-grip dynamometer","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"40","spread":"13"},{"groupId":"OG001","value":"38","spread":"12"}]}]}]},{"type":"SECONDARY","title":"Health Related Quality of Life: SF-36, Physical Component Summary (PCS)","description":"Baseline-adjusted quality of life as assessed with the 36-item short form survey (SF-36), which measures each of the following 8 health domains: 1= general health, 2= physical function, 3= role physical, 4= bodily pain, 5= vitality, 6= social function, 7= role emotional, 8= mental health. Total score for each domain are scaled 0 (minimum) to 100 (maximum), where higher scores represented higher level of functioning. Two norm-based sum scores, the physical and the mental component summaries with a mean of 50±10, were generated from the eight scale scores using a T-score transformation. Higher scores represented higher level of functioning.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"49","spread":null},{"groupId":"OG001","value":"45","spread":null}]}]}]},{"type":"SECONDARY","title":"N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP)","description":"The between-group difference in baseline-adjusted NT-proBNP","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"421","spread":null},{"groupId":"OG001","value":"349","spread":null}]}]}]},{"type":"SECONDARY","title":"Cardiac Troponin T (TnT)","description":"The between-group difference in baseline-adjusted TnT","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13.0","spread":null},{"groupId":"OG001","value":"15.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Health Related Quality of Life: SF-36, Mental Component Summary (MCS)","description":"Baseline-adjusted quality of life as assessed with the 36-item short form survey (SF-36), which measures each of the following 8 health domains: 1= general health, 2= physical function, 3= role physical, 4= bodily pain, 5= vitality, 6= social function, 7= role emotional, 8= mental health. Total score for each domain are scaled 0 (minimum) to 100 (maximum), where higher scores represented higher level of functioning. Two norm-based sum scores, the physical and the mental component summaries with a mean of 50±10, were generated from the eight scale scores using a T-score transformation. Higher scores represented higher level of functioning.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"56","spread":null},{"groupId":"OG001","value":"53","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":5,"n":52},"commonTop":["Infection","Bleeding","Musculoskeletal pain","Gout","Generalized Rash"]}}}